pediatrics
Respiratory Syncytial Virus (RSV) and Human Metapneumovirus Infections
More Information
The following English-language resources may be useful. Please note that THE MANUAL is not responsible for the content of these resources. American Academy of Pediatrics (AAP):Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection(2014) ACIP and AAP:Recommendations for the Use of the Monoclonal Antibody Nirsevimab for the Prevention of RSV Disease(2023) CDC:Limited Availability of Nirsevimab in the United States—Interim CDC Recommendations to Protect Infants from Respiratory Syncytial Virus (RSV) during the 2023–2024 Respiratory Virus Season CDC:Urgent Need to Increase Immunization Coverage for Influenza, COVID-19, and RSV and Use of Authorized/Approved Therapeutics in the Setting of Increased Respiratory Disease Activity During the 2023–2024 Winter Season 